Delivery Order SPE2DB24D1205-SPE2DB25FCZMT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,478.51 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with a completion date of July 31, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,413.45 for Ondansetron ODT 4 mg tablets (30-count supply) on August 1, 2025, with a completion date of August 4, 2025. This non-competitive, firm fixed price delivery order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a continuation of the company's extensive pharmaceutical supply relationship with DLA, supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $3,686.07. This competitively awarded, firm fixed-price delivery order represents a continuation of the contractor's critical role in supporting federal pharmaceutical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,254.19 on August 4, 2025. This firm fixed-price delivery order, which is scheduled for completion by August 5, 2025, represents a non-competitive set-aside award under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical distributor will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $7,389.26. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,100.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $8,939.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $28,723.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive award to the pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is part of...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency's Medical Supply Chain to provide Ondansetron ODT 4 mg tablets (30-count) with a firm fixed price ceiling value of $5,173.92. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with...
- The Defense Logistics Agency awarded a $6,475.18 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 28, 2025, with completion targeted for July 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZMTDelivery Order
The Defense Logistics Agency awarded a $4,230.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This award was made on a competitive, non-set-aside basis and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location at the same address, providing this antiemetic medication to support federal medical procurement needs for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 prime indefinite delivery vehicle with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support mechanism. The parent contract enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitive delivery orders demonstrates its capability as a critical vendor within the DLA Medical Supply Chain and positions it to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/13/25 |